---
figid: PMC6626370__13148_2019_696_Fig2_HTML
figlink: /pmc/articles/PMC6626370/figure/Fig2/
number: F2
caption: Convergent inflammatory signaling through NF-κB potentiates BRD4-dependent
  transcription of VI mediators, a result suppressed by apabetalone. a MCP-1, LPS,
  IL-1β, and TNFα all signal through NF-κB. The stimulants MCP-1, LPS, IL-1β, and
  TNFα activate their cognate receptors CCR2, TLR, IL-1R, and TNFR respectively. The
  receptors translate the signal through AKT, MYD88 and TRADD, phosphorylating NF-κB
  (yellow “p” circles) and releasing RelA-p50 subunits from IκBα. RelA translocates
  to the nucleus where it binds to consensus DNA binding sequences and is acetylated
  at K310 by p300 (black “a” circles). BRD4 recognizes and binds to these acetylation
  marks, recruiting pTEFb to activate RNA Pol II to drive inflammatory gene expression
  (cytokines, chemokines, and adhesion molecules). b Apabetalone (green 7-point star)
  competitively inhibits BRD4 BD2 interactions with acetylated lysine marks on RelA.
  This prevents pTEFb recruitment and Pol II activation, inhibiting the transcription
  of VI mediators and components of the NF-κB pathway. Green boxes and red arrows
  indicate genes in the illustration whose expression is reduced by apabetalone
pmcid: PMC6626370
papertitle: Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD
  patients by a BET-dependent epigenetic mechanism.
reftext: Laura M. Tsujikawa, et al. Clin Epigenetics. 2019;11:102.
pmc_ranked_result_index: '143481'
pathway_score: 0.8726309
filename: 13148_2019_696_Fig2_HTML.jpg
figtitle: Convergent inflammatory signaling through NFKB potentiates BRD4-dependent
  transcription of VI mediators, a result suppressed by apabetalone
year: '2019'
organisms:
- Homo sapiens
ndex: 9c6efe2a-df0d-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6626370__13148_2019_696_Fig2_HTML.html
  '@type': Dataset
  description: Convergent inflammatory signaling through NF-κB potentiates BRD4-dependent
    transcription of VI mediators, a result suppressed by apabetalone. a MCP-1, LPS,
    IL-1β, and TNFα all signal through NF-κB. The stimulants MCP-1, LPS, IL-1β, and
    TNFα activate their cognate receptors CCR2, TLR, IL-1R, and TNFR respectively.
    The receptors translate the signal through AKT, MYD88 and TRADD, phosphorylating
    NF-κB (yellow “p” circles) and releasing RelA-p50 subunits from IκBα. RelA translocates
    to the nucleus where it binds to consensus DNA binding sequences and is acetylated
    at K310 by p300 (black “a” circles). BRD4 recognizes and binds to these acetylation
    marks, recruiting pTEFb to activate RNA Pol II to drive inflammatory gene expression
    (cytokines, chemokines, and adhesion molecules). b Apabetalone (green 7-point
    star) competitively inhibits BRD4 BD2 interactions with acetylated lysine marks
    on RelA. This prevents pTEFb recruitment and Pol II activation, inhibiting the
    transcription of VI mediators and components of the NF-κB pathway. Green boxes
    and red arrows indicate genes in the illustration whose expression is reduced
    by apabetalone
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR10
  - TLR6
  - RELA
  - AKT2
  - CXCL13
  - CXCL1
  - BRD4
  - CCR2
  - CXCL8
  - CXCL10
  - CXCL2
  - CXCL3
  - EP300
  - TRADD
  - CXCL11
  - CXCL5
  - CXCL12
  - CXCL14
  - HMGB1
  - IL1R1
  - IRF6
  - CCL2
  - NFKB1
  - NFKB2
  - RELB
  - TNFRSF1A
  - AKT3
  - AKT1
  - CXCL6
  - TLR1
  - TLR7
  - TLR8
  - TLR9
  - REL
  - TLR2
  - TLR3
  - TLR4
  - PF4
  - PPBP
  - CXCL9
  - TNF
  - TLR5
  - LPS
genes:
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: RelA
  symbol: RELA
  source: hgnc_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL13
  entrez: '10563'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: BRD4
  symbol: BRD4
  source: hgnc_symbol
  hgnc_symbol: BRD4
  entrez: '23476'
- word: CCR2
  symbol: CCR2
  source: hgnc_symbol
  hgnc_symbol: CCR2
  entrez: '729230'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL2
  entrez: '2920'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL3
  entrez: '2921'
- word: p300
  symbol: p300
  source: hgnc_alias_symbol
  hgnc_symbol: EP300
  entrez: '2033'
- word: TRADD
  symbol: TRADD
  source: hgnc_symbol
  hgnc_symbol: TRADD
  entrez: '8717'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL11
  entrez: '6373'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL5
  entrez: '6374'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL14
  entrez: '9547'
- word: HMGB1
  symbol: HMGB1
  source: hgnc_symbol
  hgnc_symbol: HMGB1
  entrez: '3146'
- word: IL-1R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: LPS
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: MCP-1
  symbol: MCP-1
  source: hgnc_alias_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: TNFR
  symbol: TNF-R
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL6
  entrez: '6372'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PF4
  entrez: '5196'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PPBP
  entrez: '5473'
- word: chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: TNFa
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
chemicals: []
diseases:
- word: LPS
  source: MESH
  identifier: C536528
figid_alias: PMC6626370__F2
redirect_from: /figures/PMC6626370__F2
figtype: Figure
---
